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!he Site of Emetic Action of Veratrum Derivatives 
Emesis, or the act of vomiting, is a common occurrence after the 
administration of a large number of drugs. Many of these drugs would 
have ~etter clinical application if this side action could be controlled 
or abolished. The study o1' drug induced emesis has mainly centered 
around the determination of the site of the emetic action. It is at 
present concluded that emesis may be the result of local irritation 
of so~e area of the body such as the duodenum or the result of direct 
stimulation of the vomiting center in the medulla. 
The location of the vomiting center in the medulla was first 
described by Thumas in 1891. Hatcher and Weiss (10) in 1924 localized 
the v~miting center to the area of the sensory nucleus of the vagus. 
Borison and Wang (1) in 1949 more accurately localized the vomiting 
center in the region corresponding to the solitary fasciculus and 
nucleus, and the dorsolateral border of the lateral reticular forma-
tion in the medulla. Further investigations by Borison and Wang (2) 
have indicated the presence of an area on the floor of the fourth ven-
tricle which might be considered to be a chemoreceptor area for cen-
trally acting emetics. They have also concluded that the center for 
emesie is localized in the area of the reticular formation. 
The methods described in the literature for the determination of 
the sites of emetic action of various drugs are numerous. The effect 
of route of administration on drug induced emesis has been studied 
by Eggleston and Hatcher (7). They demonstrated that emesis occurs 
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much more rapidly after intramuscular injection of apomorphine than 
after introduction into the stomach. They concluded that this is not 
suggestive of local action but might imply only a different rate of 
adsorption. The uniformity of dosage for a given route of administra-
tion of apomorphine has also been demonstrated (7). This suggested 
that the emetic action is upon a highly specialized structure such as 
the vomiting center. 
Application of a drug to the central vomiting apparatus has been 
utilized in the study of emesis. Hatcher and Weiss (9) succeeded in 
causing emesis by the direct application of apomorphine to the floor 
of the fourth ventricle. Hatcher and Weiss (12) have also used this 
method in the study of digitalis induced emesis. They were unsuccessful 
in causing emesis by direct application of digitalis bodies to the 
floor of the fourth ventricle. This type of experiment is not critical 
since many factors are involved, such as the abnormality of the animal 
after exposing the fourth ventricle. 
Several methods have been described for the determination of the 
role of irritation of the gastrointestinal tract in drug induced emesis. 
Eggleston and Hatcher (7) performed a series of experiments in which 
removal of the entire gastrointestinal tract and cocainization of the 
esophagus and pharynx did not prevent retching after administration of 
apomorphine. Hatcher and Eggleston (9) utilized eviscerated dogs in 
their study of digitalis. They demonstrated that digitalis still caused 
retching in these dogs. Sadusk (16) made use of complete gastrointes-
tinal evisceration to show that irritation of the gastrointestinal tract 
===~ - --
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is not involved in sulfapyridine induced emesis. 
Denervation of an organ or a particular region of the body has been 
utilized to a considerable extent in the study of emesis. Hatcher and 
Weiss (11) have reported that denervation of the abdominal viscera by 
sectioning of the vagi and splanchnics below the diaphragm did not 
interfere with emesis after the administration of digitalis bodies. 
They concluded from these results that irritation of the abdominal vis-
cera is not the cause of digitalis induced emesis. Hatcher and Weiss (12)\: 
have performed experiments to determine the role of the thoracic vis-
cera in digitalis induced emesis. They reported that removal of stellate 
ganglia or sectioning of the cord above the level at which the sympa-
thetic cardiac fibers enter usually prevented nausea and vomiting after 
the administration of digitalis bodies. Contrariwise, Dresbach and 
Waddel (5), working on the same problem, found that removal of the cer-
vical ganglia, the stellate ganglia and the thoracic chain and section-
ing of the vagus nerves either individually or in combination did not 
prevent emesis after administration of digitalis bodies. The difference 
in results of these two groups of workers can perhaps be explained by 
the fact that Hatcher and Weiss (12) allowed only a few hours while 
Dresbach and Waddel (5) allowed a few weeks for recovery of the animals 
after the operation. Haney and Lingren (8) have presented evidence which 
tends to support the results of Dresbach and Waddel. They used two sets 
of dogs (1), the hearts were denervated by bilateral removal of the 
stellate and upper six thoracic sympathetic ganglia and sectioning of 
both vagi (2). The vagi were cut high in the neck and the spinal cord 
3 
was sectioned at C6 and pithed from that point caudally. The production 
of emesis by digitalis bodies was not abolished in these animals. Kwit 
and Hatcher (13) have also used the method of denervation of the heart 
to demonstrate that pilocarpine induced emesis is caused by irritation 
of receptors on the heart. 
The use of various agents such as atropine has also been utilized 
in the study of drug induced emesis. Hatcher and Weiss (11). have re-
ported that the injection of nicotine with atropine abolished the emetic 
action of an intravenous or intramuscular dose of a digitalis body but 
it does not abolish that of an intraperitoneal dose of strophanthidin. 
It was also shown that nicotine with atropine does not depress the 
vomiting center markedly since it does not abolish the emetic action of 
apomorphine. It was concluded therefore that nicotine abolished the 
emetic action of digitalis bodies by paralyzing afferent endings or 
possibly by paralyzing the connections in the ganglia through which the 
afferent fibers from the heart to the vomiting center pass. It was 
also shown that nicotone does not abolish the emetic action of irritants, , 
including strophanthidin and mercuric chloride, when they are applied 
directly to the peritoneum. Kwit and Hatcher have also used atropine 
in their study of pilocarpine induced emesis. They reported that ad-
ministration of atropine (5 mgm in 1% solution) to the gastric or intes-
tinal mucosa prevented both copper sulfate and pilocarpine induced 
emesis. The intravenous injection of 0.01 mgm of atropine abolished 
the emetic action of a minimal dose of pilocarpine but 500 times that 
dose had no effect on the emesis after administration of apomorphine. 
~:.:...~~~:;.--··-----:Ti-:-.=::;:.:..=..=--==.:;;;::..=:=::=::.=:::.-::.-~_;.;_;:::::..:..:....~~..::=..::=--:.=....::::::==.::~-:::::_- •.. 
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They therefore concluded that moderate doses of pilocarpine caused emesis" 
l: 
by their peripheral action. 
Perfusion experiments have also been used in the study of digitalis , 
induced emesis. Hatcher and Weiss (12) demonstrated that nausea and 
vomiting could not be elicited in decerebrate cats by perfusing the 
brain and medulla with defibrinated blood to which ouabain had been 
added. Preventing the digitalis bodies from reaching the medulla (after 
injection into the femoral vein) by perfusing the medulla with diluted 
defibrinated blood did not prevent emesis from occurring. They there-
fore concluded that digitalis bodies cause emesis by a peripheral action. ,' 
A new technique for the study of the problem of emesis has been 
described by Borison and Wang (3). Their technique consists of destroy-
ing the chemoreceptor areas for centrally acting emetics. This area 
is located on the floor of the fourth ventricle. They have reported 
that destruction of this area prevents apomorphine induced emesis but 
does not prevent emesis due to local irritation such as that observed 
with copper sulfate. They too have studied the problem af digitalis 
induced emesis. Their results indicate that the emesis observed within 
1 to 3 hours after administration of digitalis is due to a central action. 
>I 
The possibility that digitalis may produce emesis by a peripheral action 
is still admitted since emesis may occur occasionally even though the 
central chemoreceptor area is destroyed. 
From this review of the literature it may be concluded that (1) 
no completely satisfactory technique exists for the study of the problem 
of emesis after drug administration. (2) A series of indirect experi-
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ments must be performed to determine the site or sites of emetic action 
of a drug (3). The possibility of more than one site of emetic action 
of a drug must be conside~ed. 
The hypotensive power of veratrum derivatives has been known for 
years but variability of response and the side action of nausea and 
vomiting has considerably reduced its clinical application. Continued 
success in isolation of purified veratrum derivatives has again stim-
ulated. clinical interest in these plants. The pharmacology of these 
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veratrum derivatives has yet to be clearly described. The site of 
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cardioi 
:I li vascular action of these substances is still much in dispute. The 
fate in the body and the mode of excretion of these derivatives remains 
to be determined. The problem is still further complicated by the fact 
that very small amounts (meg per Kg) are required to produce an effect 
in the body. ThUs the site of emetic action of veratrum derivatives 
was thought worthy of investigation. Several of the methods previously 
described have been used. For many of these derivatives the emetic 
dose had not previously been determined, hence this was the first step. 
Following the procedures used by Eggleston and Hatcher (7) for the de-
termination of emetic site of apomorphine, the influence of route of 
administration and the constancy of dosage by a given route was deter-
!i 
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!! The procedure of using other drugs such as atropine in the study 11 
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mined. 
of emesis as presented by Kwit and Hatcher (13) was also utilized. 
Denervation of the gastrointestinal tract, as described by Hatcher and 
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Weiss (10), was performed to determine if irritation of the gastro- 'I 
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intestinal tract is the cause of emesis after administration of veratrum. II 
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Thus, this investigation has been divided into several series of ex-
periments, each of which will be considered separately. 
(A) Determination of the emetic dose 50 (ED50) for several veratrum 
derivatives: 
Method: Adult mongrel dogs (5 - 15 Kg) were weighed to the nearest 
I 
i 
I 0.1 Kg. The veratrum derivatives were administered by vein in 5 ml. of 
physiologic saline. The dogs were observed for a period of 2 hours II 
(actually all emesis occurred within the first 20 minutes). A sufficient I 
number of animals were used to obtain a significant Chi2 value as de-
termined by the method of Litchfield and Wilcoxon (14). 
Results: In Table I are listed the ED50 values for the derivatives. 
In Figure 1, the ED50 values of these derivatives are plotted against 
standard hypotensive potency (15). Excessive salivation constantly 
preceded emesis. The dogs collapsed and convulsed for a period of 15 
to 45 seconds after the administration of an effective intravenous 
emetic dose. This effect may be a hypotensive syncope. Every animal 
which had emesis also had repeated defecation which occurred almost 
simultaneously with the emesis. 
Discussion: The right hand column of Table I represents the ED50 values 
with 95% confidence limits after conversion to the standard hypotensive 
dose of 1. The difference in these figures is not statistically sig-
nificant. Thus, there is a correlation between emetic dose and hypo-
tensive dose. This is illustrated in Figure 1, which shows a straight 
I 
line relationship between the log of the hypotensive potency and the log ' 
of the ED50 values • 
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Christenson and McLean (4) have suggested a bioassay for veratrum 
derivatives based on pigeon emesis. They made no comparison of its 
emetic properties and hypotensive powers in the same species. In this 
present investigation, the emetic properties and hypotensive potency 
are compared in the dog. These results indicate another potential 
assay method for veratrum based on emesis in dogs. 
Veriloid was selected as the reference standard and for use in 
the following experiments because it is an alkaloidal mixture of constant 
potency, and because the total available information about its actions 
is greatest. 
(B) Comparison of the oral and the intravenous emetic dose of Veriloid. 
Method: Adult mongrel dogs (5 - 15 Kg) were weighed to the nearest 
0.1 Kg. The intravenous dose was dissolved in 5 ml. of physiologic 
saline and was administered rapidly into the foreleg vein. The oral 
dose was administered by stomach tube in a total vollml.e of 20 ml. Ten 
dogs received intravenous or oral administrations of various dosages of 
Veriloid on successive days. 
Results: In Table II are presented the results of a large series of 
animals. The ED 50 values were calculated by the method described by 
Litchfield and Wilcoxon (14). After intravenous administration of an 
effective emetic dose, the majority of animals had emesis within 3 to 5 
minutes. The interval before emesis after an effective oral emetic 
dose varied from 5 to 80 minutes. No syncope was observed after oral 
administration of an effective emetic dose. 
Table III presents the results of repeated intravenous injections 
--~~=============== ==================== 
j: 
of various dosages on successive days. The results demonstrate that 
there exists a dosage which will constantly cause emesis in an ind.ivi-
dual dog. This dose has been called the minimum effective intravenous 
emetic dose. 
Discussion: The difference between the ED50 for oral administration 
and the ED50 for intravenous administration is not statistically sig-
nificant. Thus the oral emetic dose may be considered equal to the 
intravenous emetic doae. The results of this series of experiments 
might indicate that (1) Irritation of the gastrointestinal tract after 
oral administration o: Veriloid is the cause of emesis and that 
Veriloid after intravenous administration circulates to the gastro-
intestinal tract to also cause emesis. (2). After intravenous 
administration, Veriloid causes emesis by stimulation of some highly 
specialized structure such as the vomiting center and that Veriloid 
is quantitatively absorbed from the gastrointestinal tract to also 
cause stimulation of the vomiting center. The latter seems more likely 
since emesis occurs so much earlier after intravenous administration 
than after oral administration of an effective dose. Further proof is 
indicated by the fact that the minimum effective intravenous emetic 
dose for an individual dog is constant (see Table III). 
(C) Influence of rate of administration of an emetic dose. 
(a) Oral. 
Method: Twelve adult mongrel dogs (17 - 28 Kg) were weighed to the 
nearest 0.1 Kg. Each animal was tested twice with each of three forms 
of tablets; rapidly dissolving, enteric coated and slow dissolving. 
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Each animal received a total dose of 1.0 mg. The tablets were admin-
istered orally in a small piece of meat. The times required for emesis 
varied considerably and are of no significance. The dogs were observed 
for four hours at the end of which time if emesis had not occurred, the 
experiment was considered negative. 
Results: The results of administration of the three different types of 
tablets are presented in Table IV. 
Discussion: To account for the results of these experiments several 
assumptions might be made: (1) In some of the animals the enteric 
coated and slow dissolving tablets passed through the gastrointestinal 
tract unchanged. This would account for the lower incidence of emesis 
with these tablet forms (2). Irritation of some portion of the gastro-
intestinal tract, such as the duodenum, is the cause of emesis and the 
rate at which the drug reaches this area determine the appearance of 
emesis (3). The rate of absorption from the gastrointestinal tract 
determines the incidence of emesis. This would explain why the slow 
dissolving tablets are the least emetic of the three forms tested. 
(b) Intravenous. 
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Method: Slow infusion experiments: Nine adult mongrel dogs ( 7 - 12 Kg) jl 
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were weighed to the nearest 0.1 Kg. A dilute solution of Veriloid was \1 
ii 
administered by vein at a rate of 0.5 meg per Kg per minute until emesis d li li 
occurred or until a total dose of 23 meg per Kg was administered. A li I 
II 
total dose of 23 meg per Kg was selected because it represents an !i 
II 
ED90 value (a dose which will cause 90% of the animals to have emesis) I! 
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as determined from the results of section (A). The following day, any 
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animal which did not have emesis after the infusion of 23 meg per Kg 
was given a quick injection of the same dose. It was assumed that if 
the animal did not have emesis with the quick injection, a negative 
response after infusion of the same dose was to be expected. Following 
the same procedure, a ieries of eight dogs were infused with a dose of 
23 meg per Kg at the rate of ~ meg per Kg per hour. 
Results: In Table V are presented the results of the slow rate of 
intravenous administration of Veriloid. At this rate of adrrdnistration, 
no syncope was observed. The results of the hourly intravenous inject-
ions of Veriloid are presented in Table VI., Emesis occurred after the 
first injection in only four cases of 38 trials (3 at dose of 15 meg 
per Kg) indicating that the individual dose was a sub-emetic one in 34 
animals. No emesis was observed in the series of eight animals infused 
with f; meg per Kg per minute. 
Discussion: The results of this series of experiments make it unlikely 
that emesis after administration of Veriloid is due to the hypotensive 
effect of the substance since other work suggests that the duration of 
the hypotensive effect of doses below 10 meg would not last one hour. 
These results also imply that the rate of destruction or excretion of 
Veriloid or the emetic cleavage products is less than 7.5 meg per Kg 
per hour but more than 5 meg per Kg per hour. It is also of interest 
to note that the cumulated emetic dose is but little higher than the 
single emetic dose. 
(D) Attempted drug control of Veriloid induced emesis. 
Method: Adult mongrel dogs were used. An effective intravenous emetic 
============================================================~~-======~-
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dose was given each dog a day before any other drug was administered. 
Three injections served as controls for the individual animals. Intra-
• venous injections of tetraethylammonium chloride (Etamon) and Banthine 
were given 10 minutes before intravenous Veriloid. Intravenous atropine 
was given 10 minutes prior to oral administration of Veriloid. Oral 
Banthine and intravenous ephedrine and scopolamine were given 30 minutes 
before intravenous Veriloid. Oral dramamine was given 40 to 60 minutes 
prior to administration of Veriloid. The dosage per Kg for oral &ram-
amine varied in the different animals between 3.5 and 16.4 mg. The 
remaining drugs were administered on a mg per Kg basis. All animals 
were observ-ed for a period of 2 hours after Veriloid was administered. 
Results: Table VII contains the results of this series of experiments. 
The dosages of scopolamine and atropine used were sufficient to cause 
hyperactivity in many of the dogs. Scopolamine appeared to be of 
possible benefit in the control of emesis. No significant decrease in 
the incidence of Veriloid induced emesis was observed with atropine. 
The results suggest that a full pressor dose of ephedrine may decrease 
the incidence of emesis. Oral dramamine in doses up to 16.4 mg per Kg 
were ineffective in preventing emesis. A high intravenous dose of 
Banthine appeared to be of some benefit in emesis control. A blocking 
dose of tetraethyl-ammonium chloride had no effect on the incidence of 
emesis. 
• 
Discussion: The slight beneficial results of scopolamine and Banthine 
are not significant, because the dose used was too hj.:gh to be of any 
practical value. Although Kwit and Hatcher (13) have reported that 
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atropine abolishes the emesis after oral administration of a local 
irritant, the usefullness of this drug for the control of emesis is 
doubtful. Thus, the negative results obtained in this present series 
of experiments are of no significance. These results, however, do 
support the fact that as yet no drug has been tested which alleviates 
veratrum induced emesis. 
(E) The role of the stomach in emesis after administration of veratrum 
derivatives. 
Method: In 30 dogs, the pylorus was ligated under thiopental anesthesia. 11 
II After sufficient time was allowed for recovery from the anesthesia, 10 
dogs were given a previouslY determined effective oral emetic dose by 
stomach tube. Ten other dogs were given 10 times the effective emetic 
oral dose by stomach tube. The remaining 10 dogs were given orally a 
capsule containing 9.6 mg per Kg of crude ground root of veratrum. If 
the animals failed to have emesis within two hours after administration 
of the drug, they were given an intravenous injection of an effective 
emetic dose. 
Results: Table VIII contains the results of this series of experiments. 
Those animals which received the intravenous dose had emesis within the 
first 20 minutes. 
Discussion: The intravenous dose was given these animals to determine 
if they were capable of having emesis after the operation for ligation 
of the pylorus. The results of the experiments in which oral dosages of 
Veriloid and crude root were prevented from escaping from the stomach, 
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factor in the production of emesis. The dose of crude root used was 
more than 10 times the standard hypotensive dose (see footnote on Table 
1). These results do not eliminate the possibility that local irri-
tation of mjcosa of the duodenum, jejunum or ileum may cause emesis. 
(F) Denervation of the gastrointestinal tract. 
Method: After the minimum effective emetic oral and intravenous dose 
had been determined, bilateral supradiaphragmatic splanchicectomy and 
vagotomy were performed on six dogs. A week was allowed for recovery 
from the operation. The minimum effective oral and intravenous emetic 
dose was then again determined. 
Results: The oral emetic dose for these six dogs was raised about four-
fold, but the intravenous emetic dose did not change (see table IX). The 
minimum effective intravenous dose for these animals was the same as 
originally determined. 
Discussion: The results of this series of experiments indicate that 
irritation of nervous receptors of the gastrointestinal tract is a 
negligible factor in the production of emesis after administration of 
Veriloid. The change in the minimum effective oral emetic dose may be 
explained on the basis of decreased activity of the gastrointestinal 
tract with poor gastric emptying after denervation. 
General Discussion: The determination of the site of emetic action of 
a drug has presented many problems to the investigator. The report of 
Eggleston and Hatcher (7) in 1912 of the vomiting center as the site 
of emetic action of apomorphine is probably the only one in which def-
inite conclusions could be presented. The determination of the site 
for digitalis bodies has involved elimination of the possibility of 
14 
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of local action on some area of the body such as the stomach, and 
accumulation of indirect evidence as to direct stimufation of the 
vomiting center. This present investigation of the site of emetic 
action of veratrum derivatives has also been concerned with the pre-
viously mentioned objectives. Using a method of denervation it has 
been demonstrated that irritation of nerve endings of the gastrointest-
inal tract is not essential for production of emesis after the adminis-
tration of Veriloid. Elimination of extreme hypotension as the cause 
of Veriloid induced emesis is still to be accomplished despite the 
fact that the intravenous emetic dose is constant regardless of the 
rate of administration. It has been demonstrated that Veriloid causes 
emesis in animals who had a full pressor dose of ephedrine. The more 
rapid production of emesis after intravenous administration than after 
oral administration of Veriloid is not in accordance with local action. 
The constancy of the minimum effective intravenous emetic dose suggests 
that the emetic action is upon a highly specialized structure such as 
the vomiting center in the medulla. 
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Table I 
"' I.V. ED50 (19/20 C.L.) for Veratrum Derivatives 
DRUG 
Germitrine 
Germerine 
Protoveratrine 
(Lilly) 
Germidine 
'1 Veriloid 
KP (J) 
Veratradine 
Ext. V. vi.ride 
USP IX 
meg/Kg. 
2.5 
(2.0 - 3.2) 
4.2 
(2.54 - 6.0) 
5.0 
(3.2 - 7.8) 
8.1 
(7.1 - 9.2) 
15.2 
(12.2 - 18.4) 
18.8 
(16.1 - 21.9) 
46.0 
(31.9 - 66.2) 
780 
(655 - 929) 
Hypotensive Potel)il' 
in Standard Dose\ .J 
0.192 
0.218 
0.416 
0.71 
1.0 
2.13 
!I 
!. 
:) 
ED50 in Terms ~k) 
or Standard Dos ' 
!I 
26.3 ' 
(20.6 - 33.3) !I 
21.84 li 
<13.2 - 31.2) !I 
'I 
22.1 !I (14.7 - 35.8) l! 
il 
I 
19.4 ii (17 .1 - 22.1) !i 
1\ 
'I 
!I 20.52 ii 
(16.5 - 24.8) II 
18.8 
(16.1 - 21.9) 
l' 
ii 
6 II 21. i: (15.0 - 31.1) :! 
!i 
18.7 
(15.7 - 22~3) 
I ~ 
(1) These data are from Maison, Gotz and Stutzman (16). The standard dose !i 
is an estimate or micrograms per kilogram per minute over a 10 minute ;, 
period required to produce an average fall of mean arterial pressure 
of 30% in a large number or anesthetized dogs. 
(2) Calculated from: ED50 divided b;r the hypotensive potenc;r in standard 
dose. This figure represents ED50 after allowing for differences in 
hypotensive potenc;r. 
(J) KP is Veriloid reference standard. 
' I; 
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Figure 1 
1.) 2.5 :J fi 7 8 9 I!) 
Hypotensive potency in standard dose** 
* Each dot represents the ED50 value for an individual veratrum derivative (See Table 1) 
** See footnote (1) on Table I) 
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Table II 
Comparison of Oral and Intravenous Emetic Dose 
ROUTE ED50 meg/Kg Number of Number of 
(19/20 C.L.) Trials Dogs 
Oral 17.0 (14.4 - 20.1) 146 124 
(Stomach Tube) 
Intravenous 19.5 (17.5 - 21.6) 192 85 
Table III 
Incidence of Emesis after Intravenous Adainistration of 
Various Dosages of Veriloid\ 
(Times Emesis / Times Tested) 
Dog Number 10 15 18 21 25 28 
mcgL!g mcgL~ mcgl!g mcgL~ mcgL~ mcgL!g 
1 0/2 1/5 4/8 
2 0/1 0/3 2/9 8/8 
3 0/2 2/7 6/6 1/1 
4 0/1 0/7 3/6 5/5 4/4 
5 0/1 1/2 2/2 
6 0/1 1/6 4/5 6/6 
7 0/3 0/1 0/4 1/3 
8 0/2 0/3 2/2 
9 0/1 4/8 3/4 5/5 
10 0/1 0/1 0/4 5/8 
ao 
mcgf_Kg, 
5/5 
5/5 
5/5 
·I II 
1\ 
II I, 
ri 
II 
II 
il 
ll il I• II 
'I 
II 
I! I, 
II 
II 
II !! 
" II 
I! 
i! 
I' li 
" ii ii 
ll 
--- ---···--- -·----~-··---- ·--------- ~ ____ .... ·-- ·--·------ -~---- ~--. --~-- -----Tt""-~-~--------------. -- -·-----~---
Table IV 
Incidence of Emesis after Oral Administration of 
Various Tablet Forms* 
Tablet Form. Number of Trials Incidence of Emesis 
Rapidly Dissolving 22 
Enteric Coated 24 16 
Slow Dissolving** 24 8 
* Same 12 dogs with weight range such that the dose varied from 35 -
58 meg per .Kg. 
** Xhe slow dissolving tablets were shellac bound with estimated disin-
tegration time of 40 minutes. 
)I 
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Table V 
Influence of Rate of Administration on Veriloid1 Induced 
Emesis ( Intravenous ) 
I' 
i! 
li ,, 
,, 
" ii il 
II I, 
l· 
li 
II 
Dog Number Rate Time of Emesis (min.) Total Dose Control statil 
Admin. I.V. Inject~n after start of infusion 
(meg/Kg) 11 -----------------------_.lO;;~"---------- il 
18 li 
II 
I' 
I! 
I 
1 ! meg per .36 
Kg per min. 
j, 
2 .. 46 2.3 r ----------------------------~1 
!! 
n 2.3 Negative 
II ---------------------------------------------------~~ I,
4 It .32 16 j! II 
------------------------1! 
5 " .30 15 I! 
6 
" 
2.3 Positive 
7 
" 
26 1.3 
8 n 46 2.3 
9 
" 
25 
I ,, 
I! 
II 
'I i· 
/I 
,I 
li 
li 
!I 
;, 
I! 
ll ,, 
H I! 
II 
'I II 
il I' jl 
II 
ii 
II 
:1 
II 
,I 
I' ~I 
II 
II 
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Dose 
Table VI 
" Incidence of Emesis a.fter Hourly Injections of Veriloid 
Number of Trials i 
(meg/Kg) 
Results i[ 
(Incidence of Emesis) lj 
5 5 
5 
10 19 
12 4 
15 
All negative at 6th 
injection. 
II 
I' 
I q 
i! 
lj 
II 
il 
II 
;j 
·I 
2 negative on 6th inject~n. 
3 positive on 3rd. to 5th il 
injection. )i 
!I 
I! 5 negative, l4 positive ji 
on lst to 6th injection. II 
4 positive 3rd. to 6th 
injection. 
I' 
j, 
:I 
i 5 positive on 1st or 2nd. q 
injection. II 
Table VII 
Attempted Drug Control of Emesis after Administration 
of Veriloid1 
DRUG ROU'l'E DOSE (mg/Kg) Number with Number without 
Emesis Emesis 
Scopolamine I.M. 0.5 1* 2 
Scopolamine I.M. 0.2 1* 2 
Scopolamine I.M. 0.025 2* 1 
Atropine I.V. 1.0 7** 3 
Ephedrine I.M. 2.0 2~~ 4 
Ephedrine I.M. 1.0 4* 2 
Etamon "' I.V. 15.0 6* 0 
Dramamine11 Oral 3.5 - 7.8 6* 0 
Dramamine >l Oral 7.3 - 15.9 4* 2 
Dramamine"{ Oral 4.3 - 16.4 7* 1 
Banthine '+ I.V. 5.0 4* 3 
Banthine-. Oral 5.0 s~f- 2 li 
II 
r: 
<! 
!I * Veriloid administered intravenously in dose of 23~'~~'7/Kg 
II 
l
'·i,·.!, .! **· Veriloid administered by stomach tube in dose of 23~·vKg 
II 
II 
II 
II 
t\ 
'! 
!I 
If 
1: 
II 
li II 2 iL. 
(i 
_J= 
II 
II II 
II 
I' 
!i 
1: 
li 
1: ,, 
'I li 
.I 
'I I~ 
1: 
li 
:I 
!I 
ll 
,I 
II 
,, 
\l 
II 
:r li 
j: 
.I 
li 
It 
!i 
!' !I 
Table VIII 
Determination of Role of Stomach in Veratrum Induced 
Before Ligation 
of Pylorus 
Emesis 
After Ligation of Pylorus 
Emesis after 23 meg/Kg 
by stomach tube. 
Emesis after oral administration 
Group I 10 of 10 * 
Group II 10 of 10 • 
Group III 10 of 10 .. 
23 meg/Kg 
Veriloid 
1 of 10** 
* Projectile type of emesis. 
** Regurgitant type of emesis. 
230 meg/Kg 9.6 mgm/Kg 
Veriloid Crude Root 
3 of 10** 
3 of 10** 
Emesis after 
I,;v. Dose 
of 23 meg/Kg 
Veriloid 
8 of 9• 
8 of 8" 
6 of 7 "-
Table lX 
Effect of Denervation on Oral; and Intravenous 
Veriloid Induced Emesi~ 
Before Denervation After Denervation 
Dog Number Min. Emetic Min. Emetiq Min. Emetic Min. Emetic 
I.V. Dose Oral Dose I.V. Dose Oral Dose 
(:meg/Kg) (meg/Kg) (meg/Kg) (meg/Kg) 
1 30 28-30 30 75-125 
2 25 21-25 25 50-75 
3 18 15-18 18 60-80 
4 25 23-25 25 80-100 
5 21 18-23 21 75-100 
6 30 30 30 100-120 
I 
II 
II I. 
II !i ~~~~~t~,~-~~---=-=======-=--=-=-=--=-=-=-~==============~ 
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Veriloid (Trademark of Riker Laboratories) is a biologically stan- 111 
dardized alkaloidal extract of Veratrum viride of uniform hypo- .I 
tensive potency. I, 
11 
·I The substances utilized were kindly provided by the following 
sources: 
G. D. Searle and Company, Chicago Illinois: 
Parke Davis and Company, Detroit Michigan: 
Banthine and Dramamine 
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Abstract 
The effects of veratrum derivatives in the treatment of hyper-
tension have long appeared desirable. Their use has been mainly limited 
by the side action of nausea and vomiting. This problem of nausea and 
vomiting has been investigated by, (1) an attempt to find a veratrum 
derivative with high hypotensive potency and with low emetic properties 
by the determination of the emetic dose 50 (ED50) values for all the 
known potent alkaloids. (2) An attempt to determine the site of emetic 
action which might present an approach to the control of nausea and 
vomiting. (3) Effort to prevent veratrum induced emesis by the use 
of various antemetic drugs. 
The determination of the emetic dose 50 values for several of the 
pure ester alkaloids of veratrum was the first step in this series of 
experiments. The results are listed in Table I. There exists a close 
correlation between the emetic dose and the hypotensive dose. This is 
illustrated in Figure I, which shows a straight line relationship b,e-
tween the log of the hypotensive potency and the log of the ED50 values. 
These results suggest a method of assay for veratrum based on the emetic 
response of the dog. 
The influence of rate of administration on veratrun1 induced emesis 
has been investigated. The intravenous emetic dose was found to be 
constant regardless of the rate of administration (at least until the 
emetic dose was administered over a period of 45 minutes). The 
cumfulative effect of the emetic properties has been demonstrated by 
the fact that the intravenous injection of a sub-emetic dose once an il 
1r 
III 
li ==4~~~~ 
~ 
I! 
II 
hour caused emesis. Elimination of extreme hypotension as the cause of 
emesis has not been accomplished but these results suggest that the 
emesis observed after administratian of veratrum is not caused by the 
hypotensive action of these drugs. 
The control of emesis by the use of various agents has been invest-
igated. Tetraethylammonium chloride, atropine, scopolamine, ephedrine, 
Banthine and dramamine were found to be ineffective for alleviation of 
Veriloid induced emesis. The ineffectiveness of the pressor drug, 
ephedrine, suggested that extreme hypotension is not the cause of 
emesis. 
The role of the stomach in emesis after oral administration of 
I 
I 
I 
I 
!/ 
veratrum derivatives has been determined by ligation of the pylorus 'I) 
thus preventing the escape of an oral dose from the stomach. The results! 
of these experiments indicate that irritation of the stomach is not 
involved in the production of emesis after oral administration of 
Veriloid. These experiments also suggest that veratrum is not signifi-
cantly absorbed from the stomach. Emesis after oral administration of 
crude root of veratrum has been shown not to be due to irritation of 
'I 
'I 
II 
the stomach. I 
A series of six experiments were performed in which the gastro- I 
intestinal tract was denervated by bilateral supradiaphragmatic splanch- \ 
I 
nicectomy and vagotomy. In these animals the oral emetic dose was 
These I 
results indicate that irritation of the gastrointestinal tract is a jl 
negligible factor in Veriloid induced emesis. The change in oral emetic )J 
raised fourfold but the intravenous emetic dose remained constant. 
IV 
dose is most likely due to decrease& activity of the gastrointestinal il 1: ·ij==-'"-=~==-'-
1• 
I 
I 
I 
I v ~~--l--~~ 
tract. I 
I 
The results of this series of experiments suggest that emesis after I 
the administration of veratrum is not due to peripheral irritation but 
is the result of stimulation of the vomiting center in the medulla. 
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